Skip to main content

Table 3 Prescription determinants of intrauterine devices

From: Population characteristics of intrauterine device users in real-world clinical practice across Europe – insights from the EURAS-LCS12 study

 

LNG-IUD 8

LNG-IUD 12

LNG-IUD 20

Copper IUD

OHIUD

Total

Total number of women

8,746 (100%)

15,857 (100%)

36,185 (100%)

33,468 (100%)

2,931 (100%)

97,187 (100%)

Contraception

8,596 (98.3%)

15,490 (97.7%)

33,566 (92.8%)

33,134 (99.0%)

2,774 (94.6%)

93,560 (96.3%)

Emergency contraception

6 (0.07%)

14 (0.09%)

33 (0.09%)

648 (1.9%)

1 (0.03%)

702 (0.7%)

Heavy menstrual bleeding

789 (9.0%)

2,123 (13.4%)

9,350 (25.8%)

68 (0.2%)

645 (22.0%)

12,975 (13.4%)

Heavy menstrual bleeding only

60 (0.7%)

196 (1.2%)

1,958 (5.4%)

6 (0.02%)

102 (3.5%)

2,322 (2.4%)

Hormonal replacement therapy

26 (0.3%)

29 (0.2%)

288 (0.8%)

0 (0.00%)

14 (0.5%)

357 (0.4%)

Others

265 (3.0%)

660 (4.2%)

1,413 (3.9%)

31 (0.09%)

165 (5.6%)

2,534 (2.6%)

  1. IUD: intrauterine device; LNG: levonorgestrel; OHIUD: other hormonal IUD
  2. Note: Women may appear in more than one category